Mindray's anaesthesia delivery system gets FDA go-ahead
This article was originally published in Clinica
The US FDA has granted 510(k) clearance to Mindray Medical International's AS3000 anaesthesia delivery system. The Shenzhen, China firm described it as a "next-generation" system which "delivers precision anaesthesia and ventilation assistance with an intuitive design". Mindray estimates that the US anaesthesia delivery systems market will reach $250m this year. The AS3000 can be used in various settings including hospitals, health clinics, outpatient and ambulatory surgery centres. The system was developed by US firm Datascope, which Mindray agreed to buy in March.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.